Julie Waras Brogren
Directeur Financier/CFO chez ASCELIA PHARMA AB
Fortune : 56 872 $ au 30/04/2024
Postes actifs de Julie Waras Brogren
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASCELIA PHARMA AB | Directeur Financier/CFO | 01/01/2023 | - |
| Investor Relations Contact | 01/01/2023 | - | |
| Corporate Officer/Principal | 01/01/2020 | - | |
Ossiform ApS
 Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Julie Waras Brogren
Anciens postes connus de Julie Waras Brogren
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Bresotec, Inc. | President | 01/11/2017 | 01/06/2019 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Formation de Julie Waras Brogren
| Copenhagen Business School | Graduate Degree |
Statistiques
Internationale
| Danemark | 4 |
| Suède | 2 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ossiform ApS
Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Commercial Services |
| Bresotec, Inc. |
- Bourse
- Insiders
- Julie Waras Brogren
- Expérience
